Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection

Dimitri Lavillette, Yoann Morice, Georgios Germanidis, +7

Journal of Virology

Viral ReplicationViral DiagnosticsImmunologyHcvpp Infection AssaysAcute Phase +14

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C

Stefan Zeuzem, Jean–Michel Pawlotsky, Esther Lukasiewicz, +17

Journal of Hepatology

Disease ManagementHepatologyHepatitis CHealth PolicyViral Hepatitis +6

Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring

Alexandre Soulier, Lila Poiteau, Isabelle Rosa, +4

The Journal of Infectious Diseases

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

Valérie Castet, Chantal Fournier, Alexandre Soulier, +6

Journal of Virology

Viral ReplicationImmunologyPathologyChronic Hepatitis CTranslational Medicine +16

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C

Pierre–Yves Bochud, Stéphanie Bibert, Francesco Negro, +10

Journal of Hepatology

Autoimmune DiseaseHepatitis CHepatologyViral HepatitisImmunology +9

Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r

Slim Fourati, Christophe Rodriguez, Christophe Hézode, +5

Hepatology

Dynamics of Hepatitis B Virus Resistance to Lamivudine

Coralie Pallier, Laurent Castéra, Alexandre Soulier, +4

Journal of Virology

Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C

Stéphane Chevaliez, Alexandre Soulier, Lila Poiteau, +2

Journal of Clinical Virology

HepatologyHepatitis CViral HepatitisClinical UtilityHepatitis +5

Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy

Jean–Michel Pawlotsky, Georgios Germanidis, Pierre-Olivier Frainais, +3

Journal of Virology

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir‐containing regimen

Christophe Hézode, Stéphane Chevaliez, Giovanna Scoazec, +8

Hepatology